A breast-conserving surgery BCS is any procedure that removes cancerous tissues from the breast without removing the entire breast. BCS include:. For each procedure, a surgeon will remove cancerous tissues, and also typically removes some surrounding healthy tissue and lymph nodes depending upon the size and location of the tumor and other factors.
Forty years ago, the only option for women with breast cancer was the radical mastectomy. In the procedure, the entire affected breast is removed. The intense surgery left many women and their physicians dissatisfied with the results.
Skip to search form Skip to main content. The aim of this study was to evaluate the oncological safety of oncoplastic procedures by studying the status of the surgical margins of the excised tumor specimen in comparison with standard quadrantectomies. View on Springer.
Primitive sarcoma of the breast is a rare and challenging disease at high risk of recurrence and with poor prognosis. There are controversies in the diagnosis and management of such solid tumor due to its rarity and heterogeneity. This sarcoma is poorly responsive to both chemotherapy and radiotherapy, thus, surgery is the first and most important therapeutic approach.
Help Contact Us About us. Advanced Search. Technique for single axillary incision robotic assisted quadrantectomy and immediate partial breast reconstruction with robotic latissimus dorsi flap harvest for breast cancer : A case report.
Surgery for breast cancer treatment 2. Which type of surgery will I have? Breast-conserving surgery: lumpectomy or wide local excision 4.
Quadrantectomy is a surgical procedure in which a "quadrant" approximately one-fourth of the breast, including tissue surrounding a cancerous tumor, is removed. It is also called a partial or segmental mastectomy. Quadrantectomy is a type of breast-conserving surgery used as a treatment for breast cancer. Prior to the advent of breast-conserving surgeries, total mastectomy complete removal of the breast was considered the standard surgical treatment for breast cancer.
The aim of this study is to determine and to compare the oncological outcomes of bilateral reduction mammoplasty to standard breast-conserving surgery for breast cancer. One hundred sixty-two patients who received a quadrantectomy because of breast cancer group 1 and breast cancer patients with macromastia who underwent breast-conserving surgery via bilateral reduction mammoplasty group 2 between and were enrolled in this study. The mean follow-up time was 37 months for group 1 and 33 months for group 2.